Search

Millions of Americans have chronic shoulder pain, which can have a significant impact on quality of life. Although some get relief from medications, physical therapy, or joint injections, those with persistent pain often pursue more aggressive treatments such as surgeries and permanent neurostimulator implants.

Members of UT Southwestern Medical School’s Class of 2025 gathered with anticipation inside the Bryan Williams, M.D., Student Center gymnasium Friday morning to learn where they will begin the next phase of their training as residents.

UT Southwestern EV Charger Location, EV Charging, Electric Vehicle

website for the faculty peer coaching program within the department of anesthesiology and pain management

Harold C. Simmons Comprehensive Cancer Center is the first and only National Cancer Institute (NCI)-designated Comprehensive Cancer Center in North Texas.

If you’re planning to join family and friends to watch Super Bowl LIX, you know there will be snacks and drinks galore to tantalize you for four quarters. But to ensure you don’t go overboard with the party smorgasbord, it’s best to practice mindfulness as a key strategy, advises a lifestyle medicine expert at UT Southwestern Medical Center.

UT Southwestern Medical School’s Class of 2026 crowded inside the Bryan Williams, M.D. Student Center gymnasium for the time-honored tradition of National Match Day. At precisely 11 a.m., the soon-to-be graduates – along with thousands of other medical students nationwide – tore open the envelopes revealing where they will begin the next phase of their training as resident physicians.

A phase three clinical trial co-led by a researcher at UT Southwestern Harold C. Simmons Comprehensive Cancer Center showcases the promise of administering immunotherapy along with chemotherapy before surgery in patients with breast cancer at high risk of spreading. The findings, published in Nature Medicine, suggest preoperative immunotherapy is more effective for some breast cancer patients, the study authors say.

In Memoriam: David J. Mangelsdorf, Ph.D., pioneer in orphan nuclear receptor research and Chair of Pharmacology Published on: August 09, 2025 • By: Newsroom Share Share on Facebook Share on Twitter Share on LinkedIn Email this page Print this page DALLAS – Aug. 9, 2025 – David J. Mangelsdorf, Ph.D., …

A newly discovered “timekeeper” for fighting infections dramatically shapes the body’s immune defenses.